Looking forward to this announcement, been a while since I have been sitting on my NSB's
Time to revisit and reflect. Items to look out for in announcement
- This announcement will be Multiple Sclerosis specific.
(similar to July 2nd 2019 Spinal Chord Injury Model where the Share Price jumped from 14.5 to 43 cents, funnily enough we are now back at 14.5....)
- Neurite Growth
- Regeneration of Nerve cells.
- Effective against Copaxon, considering Spinal Chord Model was a 300% improvement against Copaxon in this announcement, which is a actual specific ''Multiple Sclerosis Drug''
